Skip to main content

Want a detailed portfolio tracker?

Dare Bioscience (DARE) P/E (2014 - 2026)

Dare Bioscience (DARE) P/E from Apr 10, 2014 to Jul 21, 2026. The TTM Dare Bioscience (DARE) P/E is -1.24. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Dare Bioscience (DARE)

YearP/EChange
2026-1.24-16.64%
2025-1.49-77.09%
2024-6.51+883.31%
2023-0.66-76.67%
2022-2.84-15.81%
2021-3.37+112.28%
2020-1.59+74.98%
2019-0.91+87.19%
2018-0.48+0.66%
2017-0.48+13.51%
2016-0.42-77.16%
2015-1.86-75.81%
2014-7.68N/A

Comparison Dare Bioscience (DARE) P/E with competitors

Dare Bioscience (DARE) P/E is -1.24.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.35%
ENLVEnlivex Ltd0.07-106.02%
FGENFibroGen Inc0.24-119.32%
CHRSCoherus Biosciences Inc0.85-168.29%
FBIOFortress Biotech Inc0.95-176.38%
ORMPOramed Pharmaceuticals Inc1.50-220.97%
AGENAgenus Inc3.01-342.23%
INVAInnoviva Inc3.15-353.85%
VXRTVaxart Inc3.55-385.70%
CRMDCorMedix Inc3.63-392.03%
CVACCureVac N.V.4.45-457.81%
GLPGGalapagos NV4.86-491.07%
SRPTSarepta Therapeutics Inc4.88-492.93%
ABEOAbeona Therapeutics Inc5.39-533.61%
ABUSArbutus Biopharma Corp5.60-550.36%
ZVRAZevra Therapeutics Inc5.89-573.83%
SPROSpero Therapeutics Inc6.23-601.30%
CGENCompugen Ltd6.31-608.18%
RIGLRigel Pharmaceuticals6.87-653.10%
SLXNSilexion Therapeutics Corp7.30-687.23%
OMEROmeros Corporation9.26-845.19%
AUPHAurinia Pharmaceuticals Inc9.58-871.45%
PLXProtalix BioTherapeutics Inc10.89-976.56%
ACADAcadia Pharmaceuticals Inc11.73-1043.97%
TBPHTheravance Biopharma Inc12.26-1086.92%
ADMAAdma Biologics Inc12.42-1099.48%
HRMYHarmony Biosciences Holdings Inc13.82-1212.32%
SABSSAB Biotherapeutics Inc14.14-1237.76%
NAGENiagen Bioscience Inc14.82-1292.64%
INCYIncyte Corp15.82-1373.48%
REGNRegeneron Pharmaceuticals Inc15.86-1376.23%
PBYIPuma Biotechnology Inc17.32-1493.66%
CPRXCatalyst Pharmaceuticals Inc17.44-1503.61%
EXELExelixis Inc17.54-1511.55%
TGTXTG Therapeutics Inc18.97-1626.49%
MDXGMimedx Group Inc20.55-1754.18%
XOMAXOMA Royalty Corp22.87-1941.12%
ARGXArgen X SE24.30-2055.68%
CTMXCytomX Therapeutics Inc24.82-2097.79%
XOMAOXOMA Royalty Corp25.34-2139.94%
HALOHalozyme Therapeutics Inc25.62-2162.39%
XOMAPXOMA Royalty Corp25.67-2166.12%
VRTXVertex Pharmaceuticals Inc27.99-2353.22%
RPRXRoyalty Pharma plc - Class A28.69-2408.99%
SLNOSoleno Therapeutics Inc29.02-2435.37%
ASNDAscendis Pharma A/S30.09-2521.51%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3151.44%
APLSApellis Pharmaceuticals Inc39.02-3240.72%
BMRNBiomarin Pharmaceutical Inc42.21-3497.52%
KRYSKrystal Biotech Inc45.34-3749.58%
ONCBeiGene Ltd69.54-5697.13%
PHARPharming Group N.V.75.03-6138.62%
TECHBio-Techne Corp101.96-8306.37%
VCELVericel Corp109.92-8947.29%
ALNYAlnylam Pharmaceuticals Inc117.96-9594.71%
GMABGenmab140.29-11391.65%
TLXTelix Pharmaceuticals Ltd162.15-13151.27%
CORTCorcept Therapeutics Inc212.86-17232.36%